KABAKOFF DAVID S - 20 Jun 2025 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
Director
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for David S. Kabakoff
Issuer symbol
NXTC
Transactions as of
20 Jun 2025
Net transactions value
$0
Form type
4
Filing time
24 Jun 2025, 16:31:00 UTC
Previous filing
21 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KABAKOFF DAVID S Director C/O NEXTCURE, INC., 9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE /s/ Steven P. Cobourn, as attorney-in-fact for David S. Kabakoff 24 Jun 2025 0001024008

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Stock Option (Right to Buy) Award $0 +28,050 $0.000000 28,050 20 Jun 2025 Common Stock 28,050 $0.4700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of June 20, 2026 and the date of the 2026 Annual Meeting of Stockholders.